Neuropathy and other nerve problems during cancer treatment

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/neuropathy-other-nerve-problems/id43... During cancer treatment, adverse nerve and muscular side effects are common. Unfortunately, there is no treatment that will prevent these conditions, but there are therapies to help relieve these side effects. Ivo Tremont, M.D., and Karin Woodman, M.D., both assistant professors in Neuro-Oncology at MD Anderson Cancer Center, discuss some of the common neurologic and muscular disorders that...

Acoustic neuroma: advances in treatment and detection

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/acoustic-neuroma-advances/id43184821... Acoustic neuroma is a benign (not cancerous) tumor that forms in the head cavity. Acoustic neuroma generally affects hearing, balance and facial nerves. Although acoustic neuroma is not cancer, tumors can be dangerous if they grow large and press against the brainstem or brain. Paul Gidley, M.D., and Franco DeMonte, M.D., both professors in Head and Neck Surgery at MD Anderson Cancer...

Organs on a chip

submitted by: nsf

Organs on a chip systems could transform the medical drug pipeline as we know it. Biomedical engineer Ali Khademhosseini explains how he and his team at MIT are engineering tissues outside of the human body and connecting different "organs" to solve some pressing challenges.

Engineering a Smart Bandaid

submitted by: nsf

What does it take to engineer a smart bandaid? Biomedical engineer Ali Khademhosseini walks us through the future of bandaids, and how he and his team at MIT are testing them.

An in-mouth wafer to treat oral cancer– Biotech’s future

submitted by: nsf

To treat oral cancer, NSF-funded small business Privo Technologies has created a platform that delivers treatments directly to the affected area. Privo develops new classes of targeted treatments, such as chemotherapy drugs, designed to be delivered through the mouth’s mucous membranes. Privo founder Manijeh Goldberg talked about her company’s research at the 2014 BIO International Convention.

Cancer-scanning device detects residual cancer cells post-surgery – Biotech’s future

submitted by: nsf

Despite a surgeon’s best efforts, residual cancer cells often remain after a tumor is removed. Now, a technology from NSF-funded small business NovaScan detects cancer cells in living tissue in real-time. The cancer-scanning device has already been used to find breast cancer cells. NovaScan’s William Gregory talked about how the wand works at the 2014 BIO International Convention.